B lymphocytes and cancer: a love-hate relationship

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989 · see citing works

Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review

Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,314 · see citing works

The blockade of immune checkpoints in cancer immunotherapy

Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838 · see citing works

Tumor angiogenesis: therapeutic implications

Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187 · see citing works

Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025 · see citing works

Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq

Tirosh, I., Izar, B., Prakadan, S. M., Wadsworth, M. H., Treacy, D., Trombetta, J. J., Rotem, A., Rodman, C., Lian, C., Murphy, G., et al. (2016) · Science · doi:10.1126/science.aad0501 · Cited by 4,944 · see citing works

Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer

Bindea, G., Mlecnik, B., Tosolini, M., Kirilovsky, A., Waldner, M. J., Obenauf, A. C., Angell, H. K., Fredriksen, T., Lafontaine, L., Berger, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.003 · Cited by 4,390 · see citing works

B lymphocytes secrete antigen-presenting vesicles.

Raposo, G., Nijman, H. W., Stoorvogel, W., Liejendekker, R., Harding, C. V., Melief, C. J., & Geuze, H. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1161 · Cited by 3,546 · see citing works

Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor

Nishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749 · see citing works

Immune Checkpoint Blockade in Cancer Therapy

Postow, M. A., Callahan, M. K., & Wolchok, J. D. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.4358 · Cited by 2,736 · see citing works

The Concept of Immunological Surveillance

Burnet, F. M. (2015) · Progress in tumor research · doi:10.1159/000386035 · Cited by 1,659 · see citing works

Immune infiltration in human tumors: a prognostic factor that should not be ignored

Pagès, F., Galon, J., Dieu‐Nosjean, M., Tartour, É., Sautès‐Fridman, C., & Fridman, W. H. (2009) · Oncogene · doi:10.1038/onc.2009.416 · Cited by 1,090 · see citing works

CD4+ follicular helper T cell infiltration predicts breast cancer survival

Gu‐Trantien, C., Loi, S., Garaud, S., Equeter, C., Libin, M., de Wind, A., Ravoet, M., Buanec, H. L., Sibille, C., Manfouo-Foutsop, G., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67428 · Cited by 1,075 · see citing works

Paraneoplastic Syndromes Involving the Nervous System

Darnell, R. B., & Posner, J. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023009 · Cited by 1,055 · see citing works

IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases

Shen, P., Roch, T., Lampropoulou, V., O’Connor, R. A., Stervbo, U., Hilgenberg, E., Ries, S., Dang, V. D., Jaimes, Y., Daridon, C., et al. (2014) · Nature · doi:10.1038/nature12979 · Cited by 1,048 · see citing works

Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures

Dieu‐Nosjean, M., Antoine, M., Danel, C. J., Heudes, D., Wislez, M., Poulot, V., Rabbe, N., Laurans, L., Tartour, É., de Chaisemartin, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0284 · Cited by 1,033 · see citing works

Chronic Intestinal Inflammatory Condition Generates IL-10-Producing Regulatory B Cell Subset Characterized by CD1d Upregulation

Mizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R. S., & Bhan, A. K. (2002) · Immunity · doi:10.1016/s1074-7613(02)00274-1 · Cited by 978 · see citing works

PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine

Okazaki, T., Maeda, A., Nishimura, H., Kurosaki, T., & Honjo, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231486598 · Cited by 849 · see citing works

The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer

Schmidt, M., Böhm, D., von Törne, C., Steiner, E., Puhl, A. G., Pilch, H., Lehr, H., Hengstler, J. G., KÖLBL, H., & Gehrmann, M. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5206 · Cited by 837 · see citing works

Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer

Germain, C., Gnjatic, S., Tamzalit, F., Knockaert, S., Remark, R., Goc, J., Lepelley, A., Becht, E., Katsahian, S., Bizouard, G., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1611oc · Cited by 833 · see citing works

De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent

de Visser, K. E., Korets, L. V., & Coussens, L. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.014 · Cited by 826 · see citing works

CONTRIBUTION TO THE KNOWLEDGE OF SARCOMA

COLEY, W. B. (1891) · Annals of Surgery · doi:10.1097/00000658-189112000-00015 · Cited by 717 · see citing works

Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells

Olkhanud, P. B., Damdinsuren, B., Bodogai, M., Gress, R. E., Sen, R., Wejksza, K., Malchinkhuu, E., Wersto, R. P., & Biragyn, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4316 · Cited by 689 · see citing works

B-cell-derived lymphotoxin promotes castration-resistant prostate cancer

Ammirante, M., Luo, J., Grivennikov, S. I., Nedospasov, S. A., & Karin, M. (2010) · Nature · doi:10.1038/nature08782 · Cited by 638 · see citing works

Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung Cancer

Al-Shibli, K. I., Dønnem, T., Al‐Saad, S., Persson, M., Bremnes, R. M., & Busund, L. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0133 · Cited by 613 · see citing works

Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy

Shalapour, S., Font-Burgada, J., Di Caro, G., Zhong, Z., Sanchez-Lopez, E., Dhar, D., Willimsky, G., Ammirante, M., Strasner, A., Hansel, D. E., et al. (2015) · Nature · doi:10.1038/nature14395 · Cited by 611 · see citing works

FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis

Andreu, P., Johansson, M., Affara, N. I., Pucci, F., Tan, T., Junankar, S. R., Korets, L. V., Lam, J., Tawfik, D., DeNardo, D. G., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.019 · Cited by 592 · see citing works

Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma

Erdag, G., Schaefer, J. T., Smolkin, M. E., Deacon, D. H., Shea, S. M., Dengel, L. T., Patterson, J. W., & Slingluff, C. L. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3218 · Cited by 591 · see citing works

Checkpoint Blockade in Cancer Immunotherapy

Korman, A. J., Peggs, K. S., & Allison, J. P. (2006) · Advances in immunology · doi:10.1016/s0065-2776(06)90008-x · Cited by 577 · see citing works

Cytokine-producing B lymphocytes-key regulators of immunity

Lund, F. E. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.03.003 · Cited by 556 · see citing works

Antibody-independent functions of B cells: a focus on cytokines

Shen, P., & Fillatreau, S. (2015) · Nature Reviews Immunology · doi:10.1038/nri3857 · Cited by 508 · see citing works

Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses

Nishimura, H. (1998) · International Immunology · doi:10.1093/intimm/10.10.1563 · Cited by 500 · see citing works

B cells and professional APCs recruit regulatory T cells via CCL4

Bystry, R., Aluvihare, V. R., Welch, K. A., Kallikourdis, M., & Betz, A. G. (2001) · Nature Immunology · doi:10.1038/ni735 · Cited by 499 · see citing works

BLC Expression in Pancreatic Islets Causes B Cell Recruitment and Lymphotoxin-Dependent Lymphoid Neogenesis

Luther, S. A., Lopez, T., Bai, W., Hanahan, D., & Cyster, J. G. (2000) · Immunity · doi:10.1016/s1074-7613(00)80199-5 · Cited by 468 · see citing works

Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors

Milne, K., Köbel, M., Kalloger, S. E., Barnes, R. O., Gao, D., Gilks, C. B., Watson, P. H., & Nelson, B. H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006412 · Cited by 445 · see citing works

B cells inhibit induction of T cell-dependent tumor immunity

Qin, Z.-H., Richter, G., Schüler, T., Ibe, S., Cao, X.-T., & Blankenstein, T. (1998) · Nature Medicine · doi:10.1038/nm0598-627 · Cited by 440 · see citing works

Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin

Luo, J., Tan, W., Ricono, J. M., Korchynskyi, O., Zhang, M., Gonias, S. L., Cheresh, D. A., & Karin, M. (2007) · Nature · doi:10.1038/nature05656 · Cited by 436 · see citing works

Humoral immunity, inflammation and cancer

Tan, T. T., & Coussens, L. M. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.01.001 · Cited by 418 · see citing works

CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes

Nelson, B. H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001323 · Cited by 416 · see citing works

At the Bench: Preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy

Intlekofer, A. M., & Thompson, C. B. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1212621 · Cited by 374 · see citing works

PD-1 is a novel regulator of human B-cell activation

Thibult, M.-L., Mamessier, E., Gertner-Dardenne, J., Pastor, S., Just-Landi, S., Xerri, L., Chetaille, B., & Olive, D. (2013) · International Immunology · doi:10.1093/intimm/dxs098 · Cited by 365 · see citing works

Interleukin 21–Induced Granzyme B–Expressing B Cells Infiltrate Tumors and Regulate T Cells

Lindner, S., Dahlke, K., Sontheimer, K., Hagn, M., Kaltenmeier, C., Barth, T. F. E., Beyer, T., Reister, F., Fabricius, D., Lotfi, R., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3450 · Cited by 364 · see citing works

B Cells Are Required for Optimal CD4+ and CD8+ T Cell Tumor Immunity: Therapeutic B Cell Depletion Enhances B16 Melanoma Growth in Mice

DiLillo, D. J., Yanaba, K., & Tedder, T. F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903009 · Cited by 361 · see citing works

SCS macrophages suppress melanoma by restricting tumor-derived vesicle–B cell interactions

Pucci, F., Garris, C., Lai, C. P., Newton, A., Pfirschke, C., Engblom, C., Álvarez, D., Sprachman, M. M., Evavold, C. L., Magnuson, A. M., et al. (2016) · Science · doi:10.1126/science.aaf1328 · Cited by 348 · see citing works

Inhibitory Effects of B Cells on Antitumor Immunity

Inoue, S., Leitner, W. W., Golding, B., & Scott, D. E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3766 · Cited by 338 · see citing works

From mice to humans: developments in cancer immunoediting

Teng, M. W. L., Galon, J., Fridman, W.-H., & Smyth, M. J. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80004 · Cited by 337 · see citing works

Tumor Antigens

Klein, G. (1966) · Annual Review of Microbiology · doi:10.1146/annurev.mi.20.100166.001255 · Cited by 337 · see citing works

B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis

Schioppa, T., Moore, R., Thompson, R. G., Rosser, E. C., Kulbe, H., Nedospasov, S. A., Mauri, C., Coussens, L. M., & Balkwill, F. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100994108 · Cited by 328 · see citing works

B‐lymphocyte contributions to human autoimmune disease

Yanaba, K., Bouaziz, J., Matsushita, T., MAGRO, C. M. J., Clair, E. W. S., & Tedder, T. F. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00646.x · Cited by 327 · see citing works

Therapeutic B cell depletion impairs adaptive and autoreactive CD4 + T cell activation in mice

Bouaziz, J., Yanaba, K., Venturi, G. M., Wang, Y., Tisch, R., Poe, J. C., & Tedder, T. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709205105 · Cited by 315 · see citing works

Breast Cancer Lung Metastasis Requires Expression of Chemokine Receptor CCR4 and Regulatory T Cells

Olkhanud, P. B., Baatar, D., Bodogai, M., Hakim, F. T., Gress, R. E., Anderson, R. L., Deng, J., Xu, M., Briest, S., & Biragyn, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4619 · Cited by 311 · see citing works

B Cells Regulate Macrophage Phenotype and Response to Chemotherapy in Squamous Carcinomas

Affara, N. I., Ruffell, B., Medler, T. R., Gunderson, A. J., Johansson, M., Bornstein, S., Bergsland, E. K., Steinhoff, M. S., Li, Y., Gong, Q., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.026 · Cited by 305 · see citing works

B cells as antigen presenting cells

Rodríguez‐Pinto, D. (2005) · Cellular Immunology · doi:10.1016/j.cellimm.2006.02.005 · Cited by 299 · see citing works

A systematic review of humoral immune responses against tumor antigens

Reuschenbach, M., Doeberitz, M. V. K., & Wentzensen, N. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0733-4 · Cited by 281 · see citing works

Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity

Carmi, Y., Spitzer, M. H., Linde, I. L., Burt, B. M., Prestwood, T. R., Perlman, N. C., Davidson, M. G., Kenkel, J. A., Segal, E., Pusapati, G. V., et al. (2015) · Nature · doi:10.1038/nature14424 · Cited by 259 · see citing works

IMMUNOLOGICAL FACTORS IN THE PROCESS OF CARCINOGENESIS

Burnet, M. (1964) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a070310 · Cited by 240 · see citing works

Human TROP-2 is a tumor-associated calcium signal transducer

Rapani, E., Sacchetti, A., Corda, D., & Alberti, S. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980529)76:5 · Cited by 215 · see citing works

Regulatory role of mature B cells in a murine model of inflammatory bowel disease

Mizoguchi, E., Mizoguchi, A., Preffer, F. I., & Bhan, A. K. (2000) · International Immunology · doi:10.1093/intimm/12.5.597 · Cited by 206 · see citing works

Targeting of Lymphotoxin-α to the Tumor Elicits an Efficient Immune Response Associated with Induction of Peripheral Lymphoid-like Tissue

Schrama, D., Straten, P. T., Fischer, W. H., McLellan, A. D., Bröcker, E., Reisfeld, R. A., & Becker, J. C. (2001) · Immunity · doi:10.1016/s1074-7613(01)00094-2 · Cited by 192 · see citing works

Tumor infiltrating B-cells are increased in prostate cancer tissue

Woo, J. R., Liss, M. A., Muldong, M. T., Palazzi, K. L., Strasner, A., Ammirante, M., Varki, N. M., Shabaik, A. S., Howell, S. B., Kane, C. J., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-30 · Cited by 180 · see citing works

Immunosuppressive and Prometastatic Functions of Myeloid-Derived Suppressive Cells Rely upon Education from Tumor-Associated B Cells

Bodogai, M., Moritoh, K., Lee-Chang, C., Hollander, C. M., Sherman‐Baust, C. A., Wersto, R. P., Araki, Y., Miyoshi, I., Li, Y., Trinchieri, G., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3077 · Cited by 167 · see citing works

B Cells Promote Tumor Progression via STAT3 Regulated-Angiogenesis

Yang, C., Lee, H., Pal, S. K., Jové, V., Deng, J., Zhang, W., Hoon, D. S. �., Wakabayashi, M. T., Forman, S. J., & Yu, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064159 · Cited by 165 · see citing works

Inhibition of Breast Cancer Metastasis by Resveratrol-Mediated Inactivation of Tumor-Evoked Regulatory B Cells

Lee-Chang, C., Bodogai, M., Martín‐Montalvo, A., Wejksza, K., Sanghvi, M., Moaddel, R., de Cabo, R., & Biragyn, A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300606 · Cited by 162 · see citing works

Naturally occurring B-cell responses to breast cancer

Coronella-Wood, J. A., & Hersh, E. M. (2003) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0409-4 · Cited by 162 · see citing works

Antigen-driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinomas.

Nzula, S., Going, J. J., & Stott, D. I. (2003) · PubMed · Cited by 158 · see citing works

Adoptive Transfer of Tumor Reactive B Cells Confers Host T-Cell Immunity and Tumor Regression

Li, Q., Lao, X., Pan, Q., Ning, N., Yet, J., Xu, Y., Li, S., & Chang, A. E. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0207 · Cited by 158 · see citing works

The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells

Hansen, M. H., Nielsen, H., & Ditzel, H. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171460798 · Cited by 156 · see citing works

Activated Murine B Lymphocytes and Dendritic Cells Produce a Novel CC Chemokine which Acts Selectively on Activated T Cells

Schaniel, C., Pardali, E., Sallusto, F., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.3.451 · Cited by 149 · see citing works

CD5 Binds to Interleukin-6 and Induces a Feed-Forward Loop with the Transcription Factor STAT3 in B Cells to Promote Cancer

Zhang, C., Xin, H., Zhang, W., Yazaki, P. J., Zhang, Z., Le, K., Li, W., Lee, H., Kwak, L. W., Forman, S. J., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.003 · Cited by 145 · see citing works

B cell-regulated immune responses in tumor models and cancer patients

Fremd, C., Schütz, F., Sohn, C., Beckhove, P., & Domschke, C. (2013) · OncoImmunology · doi:10.4161/onci.25443 · Cited by 138 · see citing works

Anti-CD20 Antibody Promotes Cancer Escape via Enrichment of Tumor-Evoked Regulatory B Cells Expressing Low Levels of CD20 and CD137L

Bodogai, M., Lee-Chang, C., Wejksza, K., Lai, J., Merino, M. J., Wersto, R. P., Gress, R. E., Chan, A. C., Hesdorffer, C., & Biragyn, A. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4184 · Cited by 137 · see citing works

The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model

Tadmor, T., Zhang, Y., Cho, H.-M., Podack, E. R., & Rosenblatt, J. D. (2011) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-0972-z · Cited by 135 · see citing works

Positive selection and lineage commitment during peripheral B‐lymphocyte development

Pillai, S. S., Cariappa, A., & Moran, S. T. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2003.097.x · Cited by 134 · see citing works

Regulatory B cells in anti-tumor immunity

Zhang, Y., Gallastegui, N., & Rosenblatt, J. D. (2015) · International Immunology · doi:10.1093/intimm/dxv034 · Cited by 133 · see citing works

B cells and Autoimmunity

Pillai, S., Mattoo, H., & Cariappa, A. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.10.007 · Cited by 132 · see citing works

B regulatory cells in cancer

Balkwill, F. R., Montfort, A., & Capasso, M. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.10.007 · Cited by 128 · see citing works

Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer.

Chin, Y., Janseens, J., Vandepitte, J., et al. (1992) · PubMed · Cited by 126 · see citing works

Antigen-dependent B-cell development

Cariappa, A., & Pillai, S. S. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00328-x · Cited by 123 · see citing works

B Cells Are Critical to T-cell—Mediated Antitumor Immunity Induced by a Combined Immune-Stimulatory/Conditionally Cytotoxic Therapy for Glioblastoma

Candolfi, M., Curtin, J. F., Yagiz, K., Assi, H. H., Wibowo, M., Alzadeh, G. E., Foulad, D. S., Muhammad, A. G., Salehi, S., Keech, N., et al. (2011) · Neoplasia · doi:10.1593/neo.11024 · Cited by 116 · see citing works

New monoclonal antibodies against B-cell antigens: Possible new strategies for diagnosis of primary cutaneous B-cell lymphomas

Fanoni, D., Tavecchio, S., Recalcati, S., Balice, Y., Venegoni, L., Fiorani, R., CROSTI, C., & Berti, E. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.09.022 · Cited by 115 · see citing works

Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals

Ou, Z., Wang, Y., Liu, L., Li, L., Yeh, S., Qi, L., & Chang, C. (2015) · Oncotarget · doi:10.18632/oncotarget.4569 · Cited by 115 · see citing works

The immune landscape of human tumors

Bindea, G., Mlecnik, B., Angell, H. K., & Galon, J. (2014) · OncoImmunology · doi:10.4161/onci.27456 · Cited by 112 · see citing works

A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years

Nedergaard, B. S., Ladekarl, M. B., Nyengaard, J. R., & Nielsen, K. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.08.089 · Cited by 111 · see citing works

B Cells Amplify IFN-γ Production By T Cells via a TNF-α-Mediated Mechanism

Menard, L. C., Minns, L. A., Darche, S., Mielcarz, D. W., Foureau, D., Roos, D. S., Dzierszinski, F. S., Kasper, L. H., & Buzoni–Gatel, D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4857 · Cited by 107 · see citing works

TREATMENT OF INOPERABLE MALIGNANT TUMORS WITH THE TOXINES OF ERYSIPELAS AND THE BACILLUS PRODIGIOSUS

COLEY, W. B. (1894) · The American Journal of the Medical Sciences · doi:10.1097/00000441-189407000-00006 · Cited by 104 · see citing works

Cancer-Produced Metabolites of 5-Lipoxygenase Induce Tumor-Evoked Regulatory B Cells via Peroxisome Proliferator–Activated Receptor α

Wejksza, K., Lee-Chang, C., Bodogai, M., Bonzo, J. A., Gonzalez, F. J., Lehrmann, E., Becker, K. G., & Biragyn, A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201920 · Cited by 104 · see citing works

Role of Tertiary Lymphoid Structures (TLS) in Anti-Tumor Immunity: Potential Tumor-Induced Cytokines/Chemokines that Regulate TLS Formation in Epithelial-Derived Cancers

Pimenta, E. M., & Barnes, B. J. (2014) · Cancers · doi:10.3390/cancers6020969 · Cited by 99 · see citing works

Helper B Cells Promote Cytotoxic T Cell Survival and Proliferation Independently of Antigen Presentation through CD27/CD70 Interactions

Deola, S., Panelli, M. C., Maric, D., Selleri, S., Dmitrieva, N. I., Voss, C. Y., Klein, H. G., Stroncek, D., Wang, E., & Marincola, F. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1362 · Cited by 94 · see citing works

The Role of B Cells for in Vivo T Cell Responses to a Friend Virus-Induced Leukemia

Schultz, K. R., Klarnet, J. P., Gieni, R. S., et al. (1990) · Science · doi:10.1126/science.2118273 · Cited by 92 · see citing works

Evidence for an antigen-driven humoral immune response in medullary ductal breast cancer.

Coronella, J. A., Telleman, P., Kingsbury, G. A., Truong, T., Hays, S. R., & Junghans, R. P. (2001) · PubMed · Cited by 88 · see citing works

Translocation of an Intracellular Antigen to the Surface of Medullary Breast Cancer Cells Early in Apoptosis Allows for an Antigen-Driven Antibody Response Elicited by Tumor-Infiltrating B Cells

Hansen, M. H., Nielsen, H., & Ditzel, H. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2701 · Cited by 86 · see citing works

Enhanced Efficacy of Melanoma Vaccines in the Absence of B Lymphocytes

Perricone, M. A., Smith, K. A., Claussen, K. A., et al. (2004) · Journal of Immunotherapy · doi:10.1097/00002371-200407000-00003 · Cited by 81 · see citing works

B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion

Zhang, Y., Eliav, Y., Shin, S.-U., Schreiber, T. H., Podack, E. R., Tadmor, T., & Rosenblatt, J. D. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1313-6 · Cited by 80 · see citing works

B cells and their mediators as targets for therapy in solid tumors

Gunderson, A. J., & Coussens, L. M. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.03.005 · Cited by 80 · see citing works

Inhibition of IgG1 and IgE Production by Stimulation of the B Cell CTLA-4 Receptor

Pioli, C., Gatta, L., Ubaldi, V., & Doria, G. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5530 · Cited by 79 · see citing works

Anti-Tumor Immunity in B Lymphocyte-Deprived Mice

Brodt, P., & Gordon, J. (1978) · The Journal of Immunology · doi:10.4049/jimmunol.121.1.359 · Cited by 79 · see citing works

Regulatory B cells preferentially accumulate in tumor-draining lymph nodes and promote tumor growth

Ganti, S. N., Albershardt, T. C., Iritani, B. M., & Ruddell, A. (2015) · Scientific Reports · doi:10.1038/srep12255 · Cited by 77 · see citing works

B-cell Depletion Using an Anti-CD20 Antibody Augments Antitumor Immune Responses and Immunotherapy in Nonhematopoetic Murine Tumor Models

Kim, S., Fridlender, Z. G., Dunn, R., Kehry, M. R., Kapoor, V., Blouin, A., Kaiser, L. R., & Albelda, S. Μ. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31816d1d6a · Cited by 75 · see citing works

Anti-tumor immunity in B lymphocyte-deprived mice. I. Immunity to a chemically induced tumor.

Brodt, P., & Gordon, J. (1978) · PubMed · Cited by 73 · see citing works

Medullary carcinoma of the breast. Identification of lymphocyte subpopulations and their significance.

Mj, G., Hf, F., Se, M., et al. (1993) · PubMed · Cited by 70 · see citing works

Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity

Nishikawa, H., Tanida, K., Ikeda, H., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251547298 · Cited by 67 · see citing works

Objective Criteria for Crohn-like Lymphoid Reaction in Colorectal Cancer

Ueno, H., Hashiguchi, Y., Shimazaki, H., Shinto, E., Kajiwara, Y., Nakanishi, K., Kato, K., Maekawa, K., Miyai, K., Nakamura, T., et al. (2013) · American Journal of Clinical Pathology · doi:10.1309/ajcpwhueftgbwke4 · Cited by 66 · see citing works

Update on paraneoplastic syndromes

Dropcho, E. J. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000169754.38944.a4 · Cited by 65 · see citing works

Depletion of normal B cells with rituximab as an adjunct to IL-2 therapy for renal cell carcinoma and melanoma

Aklilu, M., Stadler, W. M., Markiewicz, M. A., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh280 · Cited by 60 · see citing works

Computerised counting of tumour infiltrating lymphocytes in 90 breast cancer specimens

Marsigliante, S., Biscozzo, L., Marra, A., et al. (1999) · Cancer Letters · doi:10.1016/s0304-3835(98)00379-6 · Cited by 54 · see citing works

The regulatory role of B cells in autoimmunity, infections and cancer: Perspectives beyond IL10 production

Serrán, M. G., Vernengo, F. F., Beccaria, C., Rodríguez, E. A. A., Montes, C., & Gruppi, A. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.08.048 · Cited by 52 · see citing works

Phenotypic Analysis of T Lymphocytes Isolated from Non-Small-Cell Lung Cancer

Riemann, D., Wenzel, K., Schulz, T., et al. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000237640 · Cited by 42 · see citing works

Prognostic implications of circulating anti-p53 antibodies in lung cancer - a review

Kumar, S., Mohan, A., & Guleria, R. (2009) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2008.01019.x · Cited by 41 · see citing works

Simultaneous Targeting of CD3 on T Cells and CD40 on B or Dendritic Cells Augments the Antitumor Reactivity of Tumor-Primed Lymph Node Cells

Li, Q., Grover, A. C., Donald, E. J., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1424 · Cited by 40 · see citing works

Surmounting Tumor-induced Immune Suppression by Frequent Vaccination or Immunization in the Absence of B Cells

Oizumi, S., Deyev, V. V., Yamazaki, K., et al. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31816bc74d · Cited by 40 · see citing works

Paraneoplastic syndromes

Posner, J. B., & Dalmau, J. O. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80055-6 · Cited by 40 · see citing works

The Tumor Immunoenvironment

Shurin, M. R., Umansky, V., & Malyguine, A. M. (2013) · Springer eBooks · doi:10.1007/978-94-007-6217-6 · Cited by 29 · see citing works

Medullary carcinoma is associated with expression of intercellular adhesion molecule-1. Implication to its morphology and its clinical behavior.

Bacus, S. S., Zelnick, C. R., Chin, D., et al. (1994) · PubMed · Cited by 28 · see citing works

Effect of IgG produced by tumor-infiltrating B lymphocytes on lung tumor growth.

Mizukami, M., Hanagiri, T., Shigematsu, Y., et al. (2006) · PubMed · Cited by 27 · see citing works

Human B cells produce chemokine CXCL10 in the presence of Mycobacterium tuberculosis specific T cells

Hoff, S. T., Salman, A. M., Rühwald, M., et al. (2014) · Tuberculosis · doi:10.1016/j.tube.2014.10.005 · Cited by 23 · see citing works

Tumor-infiltrating B cell immunoglobulin variable region gene usage in invasive ductal breast carcinoma

Simsa, P., Teillaud, J., Stott, D. I., Tóth, J., & Kotlán, B. (2005) · Pathology & Oncology Research · doi:10.1007/bf02893374 · Cited by 23 · see citing works

A New Paradigm for an Old Story: The Role of Regulatory B Cells in Cancer

Biragyn, A., & Lee-Chang, C. (2012) · Front. Immun. · doi:10.3389/fimmu.2012.00206 · Cited by 20 · see citing works

Tumor-Evoked Regulatory B Cells as Important Mediators of Cancer Escape

Lee-Chang, C., Bodogai, M., & Biragyn, A. (2013) · Springer eBooks · doi:10.1007/978-94-007-6217-6_22 · Cited by 1 · see citing works

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth

de Visser, K. E., & Joyce, J. A. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.016 · Cited by 4,059 · see citing works

B cells and tertiary lymphoid structures promote immunotherapy response

Helmink, B. A., Reddy, S. M., Gao, J., Zhang, S., Basar, R., Thakur, R., Yizhak, K., Sade-Feldman, M., Blando, J., Han, G., et al. (2020) · Nature · doi:10.1038/s41586-019-1922-8 · Cited by 2,731 · see citing works

The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy

Bruni, D., Angell, H. K., & Galon, J. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0285-7 · Cited by 1,586 · see citing works

Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma

Ji, A. L., Rubin, A. J., Thrane, K., Jiang, S., Reynolds, D. L., Meyers, R. M., Guo, M. G., George, B. M., Mollbrink, A., Bergenstråhle, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.039 · Cited by 1,117 · see citing works

Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profiling

Hu, Q., Hong, Y., Qi, P., Lu, G., Mai, X., Xu, S., He, X., Guo, Y., Gao, L., Jing, Z., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22300-2 · Cited by 201 · see citing works

Non-conventional Inhibitory CD4+Foxp3−PD-1hi T Cells as a Biomarker of Immune Checkpoint Blockade Activity

Zappasodi, R., Budhu, S., Hellmann, M. D., Postow, M. A., Senbabaoglu, Y., Manne, S., Gasmi, B., Liu, C., Zhong, H., Li, Y., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.05.009 · Cited by 142 · see citing works

Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma

Paillet, J., Plantureux, C., Lévesque, S., Le Naour, J., Stoll, G., Sauvat, A., Caudana, P., Tosello Boari, J., Bloy, N., Lachkar, S., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20200853 · Cited by 41 · see citing works

Computed cancer interactome explains the effects of somatic mutations in cancers

Zhang, J., Pei, J., Durham, J., Bos, T., & Cong, Q. (2022) · Protein Science · doi:10.1002/pro.4479 · Cited by 31 · see citing works

Cross‐priming of CD8+ T cells by viral and tumor antigens is a robust phenomenon

Chen, W., Masterman, K., Basta, S., Haeryfar, S. M. M., Dimopoulos, N., Knowles, B. B., Bennink, J. R., & Yewdell, J. W. (2003) · European Journal of Immunology · doi:10.1002/eji.200324257 · Cited by 84 · see citing works

PRIMING POTENCY OF THE PRODUCTS OF INDIVIDUAL REGIONS OF THE H‐2 COMPLEX AND THEIR ROLE IN THE RESTIMULATION IN SECONDARY MLC

Cukrová, V., & Rychlíková, M. (1978) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.1978.tb00652.x · Cited by 2 · see citing works

Immune System

Chase, C. C. L., & Lunney, J. K. (2019) · Wiley eBooks · doi:10.1002/9781119350927.ch16 · Cited by 10 · see citing works

The immune system

Post‐White, J. (1996) · Seminars in Oncology Nursing · doi:10.1016/s0749-2081(96)80003-9 · Cited by 8 · see citing works

Research Progress of Immune Cell Function in Patients with Recurrent Genital Herpes

You-ming, W. (2012) · Medical Recapitulate